Login / Signup

Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.

Amr SonousiHanan A MahranIbrahim M IbrahimMohamed N IbrahimAbdo A ElfikyWael M Elshemey
Published in: Pharmacological reports : PR (2021)
The present study suggests these four compounds as potential SARS-CoV-2 RdRp inhibitors, which need to be validated experimentally.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • molecular docking
  • risk assessment
  • protein kinase